REDWOOD CITY, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that the company will report its fourth quarter and full year 2015 financial results on Wednesday, February 24, 2016, after the close of financial markets. Management will host a conference call and live audio webcast on the same afternoon at 5:00 p.m. ET (2:00 p.m. PT) to discuss the financial results and provide a corporate update.
Conference Call and Webcast
To access the live conference call on Wednesday, February 24, 2016, at 5:00 p.m. ET (2:00 p.m. PT), please dial (866) 410-4428 (domestic) or (704) 908-0287 (international), conference code 54100990.
To access the live and subsequently archived webcast, visit the investor relations section of the Relypsa website at http://investor.relypsa.com. The webcast will be archived for 30 days following the call.
About Relypsa, Inc.
Relypsa, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of polymeric medicines for patients with conditions that are often overlooked and undertreated and can be addressed in the gastrointestinal tract. The Company’s first medicine, Veltassa® (patiromer) for oral suspension, was developed based on Relypsa’s rich legacy in polymer science. Veltassa is approved in the United States for the treatment of hyperkalemia. Veltassa has intellectual property protection until 2030 in the United States and 2029 in the European Union. More information is available at www.relypsa.com.
Contact:
Charlotte Arnold
Vice President, Corporate Communications
650.421.9352
IR@relypsa.com